chr21-46602231-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006272.3(S100B):c.138+47A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,561,054 control chromosomes in the GnomAD database, including 9,996 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.096 ( 926 hom., cov: 33)
Exomes 𝑓: 0.10 ( 9070 hom. )
Consequence
S100B
NM_006272.3 intron
NM_006272.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.530
Publications
8 publications found
Genes affected
S100B (HGNC:10500): (S100 calcium binding protein B) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| S100B | ENST00000291700.9 | c.138+47A>G | intron_variant | Intron 2 of 2 | 1 | NM_006272.3 | ENSP00000291700.4 | |||
| S100B | ENST00000367071.4 | c.138+47A>G | intron_variant | Intron 2 of 3 | 1 | ENSP00000356038.4 | ||||
| S100B | ENST00000397648.1 | c.138+47A>G | intron_variant | Intron 1 of 1 | 1 | ENSP00000380769.1 |
Frequencies
GnomAD3 genomes AF: 0.0965 AC: 14672AN: 152092Hom.: 926 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14672
AN:
152092
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.116 AC: 27073AN: 234090 AF XY: 0.116 show subpopulations
GnomAD2 exomes
AF:
AC:
27073
AN:
234090
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.103 AC: 145741AN: 1408844Hom.: 9070 Cov.: 22 AF XY: 0.104 AC XY: 72950AN XY: 702244 show subpopulations
GnomAD4 exome
AF:
AC:
145741
AN:
1408844
Hom.:
Cov.:
22
AF XY:
AC XY:
72950
AN XY:
702244
show subpopulations
African (AFR)
AF:
AC:
1508
AN:
32112
American (AMR)
AF:
AC:
2848
AN:
41954
Ashkenazi Jewish (ASJ)
AF:
AC:
3312
AN:
24582
East Asian (EAS)
AF:
AC:
13743
AN:
39406
South Asian (SAS)
AF:
AC:
8043
AN:
82194
European-Finnish (FIN)
AF:
AC:
5924
AN:
52576
Middle Eastern (MID)
AF:
AC:
696
AN:
5586
European-Non Finnish (NFE)
AF:
AC:
103100
AN:
1072110
Other (OTH)
AF:
AC:
6567
AN:
58324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
5915
11831
17746
23662
29577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3754
7508
11262
15016
18770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0964 AC: 14677AN: 152210Hom.: 926 Cov.: 33 AF XY: 0.0984 AC XY: 7322AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
14677
AN:
152210
Hom.:
Cov.:
33
AF XY:
AC XY:
7322
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
2027
AN:
41548
American (AMR)
AF:
AC:
1426
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
468
AN:
3470
East Asian (EAS)
AF:
AC:
1740
AN:
5168
South Asian (SAS)
AF:
AC:
519
AN:
4824
European-Finnish (FIN)
AF:
AC:
1213
AN:
10600
Middle Eastern (MID)
AF:
AC:
38
AN:
292
European-Non Finnish (NFE)
AF:
AC:
6848
AN:
67996
Other (OTH)
AF:
AC:
234
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
681
1362
2044
2725
3406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
710
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.